Barr Pharmaceuticals

Error creating thumbnail:

Barr Pharmaceuticals was a global specialty pharmaceutical company that developed, manufactured, and marketed both generic and proprietary pharmaceuticals. The company was founded in 1970 and was headquartered in Woodcliff Lake, New Jersey. Barr Pharmaceuticals was known for its significant role in the development and marketing of generic drugs.

History

Barr Pharmaceuticals was established in 1970 by Edwin A. Cohen. The company initially focused on the development and marketing of generic drugs, which are bioequivalent to brand-name drugs but are typically sold at lower prices. Over the years, Barr Pharmaceuticals expanded its product line to include proprietary pharmaceuticals.

In 2006, Barr Pharmaceuticals acquired Pliva, a Croatian pharmaceutical company, which significantly expanded its presence in the European market. This acquisition made Barr Pharmaceuticals one of the largest generic drug manufacturers in the world.

Products

Barr Pharmaceuticals produced a wide range of pharmaceutical products, including:

• Oral contraceptives
• Hormone replacement therapy drugs
• Cardiovascular medications
• Central nervous system drugs
• Oncology treatments

The company was particularly well-known for its oral contraceptives, which were a significant part of its product portfolio.

Acquisition by Teva

In 2008, Barr Pharmaceuticals was acquired by Teva Pharmaceutical Industries, an Israeli multinational pharmaceutical company. The acquisition was valued at approximately $7.5 billion and was completed in December 2008. This acquisition further solidified Teva's position as a leading global generic pharmaceutical company.

Legacy

The acquisition of Barr Pharmaceuticals by Teva Pharmaceutical Industries allowed Teva to expand its product offerings and market reach. Barr Pharmaceuticals' legacy continues through Teva's extensive portfolio of generic and proprietary drugs.

See also

• Generic drug
• Teva Pharmaceutical Industries
• Pharmaceutical industry
• Pliva